evamisole hydrochloride as adjunctive therapy in falciparum malaria

Completed

• Conditions: Falciparum malaria; Infections and Infestations; Malaria

• Registration Number: ISRCTN15314870
• Lead Sponsor: niversity of Oxford (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2005-10-14
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

1. The patient or attending relative is able and willing to give informed consent - the proposed consent form and information sheets are attached and will be translated into Burmese
2. Uncomplicated falciparum malaria
3. Patients aged 16 to 65 years old, either sex
4. No contraindications to levamisole, quinine or doxycycline therapy, like documented allergies to any of the drugs

Exclusion Criteria

1. Patient or relatives unable or unwilling to give informed consent
2. Previous antimalarial treatment within one week of admission
3. Pregnancy

Study & Design

• Study Type: Interventional
• Study Design: Not specified